StockNow
Calendar
Log in
U.S. Markets

Abbott (ABT) announces that the US FDA has approved for updates to the CardioMEMS HF System that enable new patient-facing capabilities through the CardioGuide HF App

StockNow breaking-news AI analysis

Abbott reported FDA approval of CardioMEMS HF System updates enabling new CardioGuide HF App capabilities; the supplied headline gives no further details.

1 stocks
ABTAbbott Laboratories$98.36Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

Yemeni Houthi leader Mohammed al-Bukhaiti calls for a truce, saying “no one benefits from war, according to social media reports (DETAILS LIGHT)

Geopolitics

UKMTO says a tanker transiting inbound through the Strait of Hormuz was hailed by the IRGC and instructed to turn back or be targeted; the vessel complied, with the incident occurring 11NM north of Khasab, Oman

Commodities

Saudi Arabia's East-West oil pipeline pumping reportedly halted after a new attack, AFP reports citing sources; "There was big damage and the pipeline stopped again"